European Pharmacopoeia Gets To Grips With Quality Standards for mRNA Vaccines

 
• By Neena Brizmohun

Stakeholders have until 30 June to comment on a set of common quality standards for mRNA vaccines that are said to be needed in light of rapid developments in this field and the emergence of novel vaccines coding for a range of specific antigens.

The mRNA vaccine field has developed rapidly in the past few years • Source: Shutterstock

More from Vaccines

More from Pink Sheet